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Antigen antibody interactions in Heymann nephritis (HN). L. Allegri,
C. Ferrari, G. C. Manara, E. Brianti, F. Chatelet, P. P. Dall'Aglio, P.
Ronco, and P. Verroust. Institutes of Medicine and Nephroiogy,
Pathology, and Histology, University of Parma, Parma, Italy, and
INSERM U64, Hôpital Tenon, Paris, France. HN is an experimental
model of membranous glomerulonephritis induced by rat immunization
to brushborder (BB) antigens (Ag). Binding of circulating antibodies(Ab) to the fraction of the specific 330 KD BB glycoprotein (gp330)
expressed on glomerular epithelial cell membranes was recently sug-
gested as a pathogenetic event. The aim of this work was to investigate
some aspects of the glomerular gp330-anti-gp330 antibody interactions.
Monoclonal antibodies (Mab) anti-BB Ag were produced according to
the Köhler and Milstein method (modified). 5 Mab recognized different
epitopes in vitro of gp330; they were isolated and their immunochemical
features were determined. A serum rich in specific polyclonal antibod-
ies (Pab) was raised in rabbits immunized with affinity purified gp330.
Each anti-gp330 Mab and anti-gp330 polyclonal IgO purified fraction
were injected intravenously in Sprague-Dawley rats to compare their in
vivo binding properties. After 24 hr the animals were sacrificed and the
morphological aspects examined. By immunofluorescence, fine and
disperse membranous deposits could be observed after injection of 4
out of 5 Mab; the last one gave negative results, although immunoglob-
ulin class (IgG), isoelectric point (6, 3—7) and affinity constant (l0 — l0
M1) were similar for all Mab. On the other hand, Pab injection induced
coarse and irregular IMF deposits; this aspect was related to the finding
of epimembranous electron dense deposits. In conclusion, in vivo
binding properties of five monoclonal antibodies, directed against
different epitopes of the HN nephritogenic antigen and similar for
immunochemical features, were investigated. A positive reaction was
demonstrated for four of them, while the last one was unable to react
with its specific epitope. Only serum rich in Pab, when injected, could
induce epimembranous electron dense deposits. This phenomenon
should probably be ascribed to complex interactions between several
gp330 epitopes and the specific polyclonal antibodies.
Autoimmune glomerulonephritis induced In Brown-Norway rat by
mercuric chloride. R. Sinico, A. Fornasieri, A. Castiglione, F. Ferrario,
R. Boeri, G. Colasanti, P. Bernasconi, and G. D'Amico. Division of
Nephroiogy and Service of Pathology, San Carlo Hospital, Milan,
Italy. Mercuric chloride (HgCI2) induces in the Brown-Norway rat
(BN), but not in other rat strains, a self-limited autoimmune disease
which develops in two phases characterized first by a linear IgG
deposits along the glomerular basement membrane (GBM) followed
later by a granular deposition. The aim of this study was to assess
sequentially the histological, immunohistological, and clinical modifi-
cations in HgCl2 induced experimental nephritis. Fifty BN were in-
jected subcutaneously three times a week for 1 to 2 weeks with 1 mglkg
body wt of HgCl2; 30 control BN rats were injected with distilled water.
Blood and urine samples were taken serially and animals were sacri-
ficed after 7, 14, 28, and 42 days; kidney specimens were processed for
light and immunofluorescence microscopy. Anti-GBM antibody
(ELISA), circulating immune-complexes (C lq-solid phase) and protein-
uria (Biureto) were first detectable on day 7, reached a peak at day 14,
and disappeared at day 42. A linear deposition of IgG and 1gM, together
making a slight mesangial proliferation, was found at day 7, moreover,
perivascular infiltrates of mononuclear cells were seen. The linear
pattern and the histological lesions were also present and intensified at
day 14, and in three rats treated with higher dose of HgCI2 some
subendotelial fibrinoid deposits were also found. From days 28 to 42 a
mixed immunohistological pattern was seen (linear and granular) to-
gether with a gradual disappearance of histological lesions and perma-
nence of some perivascular fibrosis. In conclusion, our data point out
that the exposure of genetically predisposed subjects to toxic agents
could induce an autoimmune glomerulonephritis (and vaculitis). The
study of this experimental model could clarify the mechanisms of
development and control of the autoimmunity in humans.
Quantitative and functional analysis of Fe receptor of circulating and
tissue phagocytes in essential mixed cryoglobulinemia. D. Roccatello, R.
Coppo, F. Malavasi, G. Martina, C. Rollino, B. Basolo, A. Amore, F.
Quarello, E. Bancale, L. M. Sena, and G. Piccoli. Divsione di
Nefrologia e Dialisi e Laboraiorio di Analisi della Nuova Astanteria
Martini, Torino, Istituto di Genetica Medica e Istituto di Patologia
Generale deli' Universitd di Torino, Italy. Functional studies on
phagocytic cells have recently stressed the role of these cells in removal
of immune materials from the bloodstream in some diseases character-
ized by tissue deposition of immune complexes. To gain insight to the
role of Fc receptors (Fc R) in essential mixed cryoglobulinemia (EMC),
we analyzed quantitatively the expression of such molecules on poly-
morphonuclear leucocytes (PMN) and assessed them functionally on
PMN, tissue macrophages, and circulating monocytes in six HLA-B8,
DR3 negative patients with EMC. The Fe receptor expression was
estimated by using the AB 8.28 monoclonal antibody (MoAb) directed
to PMN FcR and 125 I-labelled rabbit F(ab')2 fragments to mouse IgG
as a detecting system. The specific reaction of 125 I-labelled (Fab')2
with AB 8.28 MoAb bound to PMN was 0.052 nM/lx 106 PMN for
patients and 0.053 for controls (P = NS). The mean value of PMN
phagocytosis index, as determined by using Cr-1abel1ed IgO-coated
sheep red blood cells as a tag, was 0.18 in EMC patients and 0.57 in
control subjects (P < 0.05). A significant difference between patients
and normal subjects was also found in values of the half-life of
autologous erytrocytes labelled with 51Cr and sensitized with IgG
anti-Rh (D), an expression of macrophage immune clearance: mean 61.6
in patients and 32.9 in control subjects (P < 0.05). Finally, monocytes
from EMC patients showed a low phagocytosis rate of the same
particles (mean, 0.4 versus 1.02 in control subjects, P < 0.05). This
general impairment of FcR function, even in the presence of a normal
receptor expression, may play a remarkable role in tissue localization of
immune material in EMC.
Role of lnterleukln-1 in allergic reactions during hemodialysis. F.
Giacchino, S. Landolfo, G. Giraudo, G. Garetto, M. Fossato, and G.
Piccoli. Nephroiogy and Microbiology Institutes of the University of
Turin and Nephroiogy and Dialysis Units, San Giovanni Hospital,
Turin, Italy. The interleukin-l (IL-I) produced by peripheral monocytes
from 26 dialysis patients was studied to evaluate the role of mononu-
clear phagocytic cells in the mechanism of allergic reactions during
hemodialysis sessions. Sixteen patients were dialyzed with cuprophan
membrane (CU) and ten with polyacrylonitrile membrane (PAN). IL-I
activity, measured on the basis of IL-i production induced by Esche-
richia coii Iipopolysacchande (LPS) from blood monocytes, was signif-
icantly higher in CU patients than in PAN patients (stimulation index
[SI] = 3.48 0.3vs. 1.5 0.05; P>0.05),because of greater monocyte
activation induced by CU membrane. CU patients' T lymphocyte
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response to IL-I derived from normal lymphocytes (E-Rosette test) did
not differ from that of PAN patients ( % of E-Rosettes =29.4 5 vs.
27.2 3.7; ns). The fact that IL-i, induced by LPS, from circulating
monocytes studied during allergic reactions to hemodialysis sessions
with CU membrane, was very low (SI = 1.1 0.2; P < 0.02 vs
pre-dialysis values) confirms these results. It suggests that a chronic
activation of monocytes induced by CU membrane may be involved in
adverse allergic reactions during hemodialysis.
Direct interaction between polymorphonuclear neutrophils (PMN) and
dialysis membranes: Role of the electrical charges. C. Tetta, G. Camussi,
G. Segoloni, and A. Vercellone. Laboratorio di Immunopatologia,
Cattedra di Nefrologia, Divisione di Nefrologia e Dialisi, Ospedale
Molinette, Torino, Italy. The role of the electrical properties of mem-
branes in contact with blood (charge transfer, other electrochemical
phenomena) at the blood-membrane interface in the activation of
normal, human, plasma-free PMN was studied. Polymethylmethacryl-
ate (PMMA) membranes of different neutral surface net charges and
percent of water content (anionic, 71%; neutral, 70%; cationic, 75%,
Hoechst, Toray) as well as cuprophan membranes (Ennka) were finely
minced (140 mg) and incubated (10 mm, 37°C) with 1 x l0 PMN
resuspended in Tris-Tyrodes' buffer with 0.25% bovine serum albumin.
The release of lysozyme (Lys), /3-glucoronidase (13-Glu), lactic dehy-
drogenase (LDH) as well as platelet-activating factor (PAF)-like aggre-
gating activity was investigated in the supernatants. Lys, 13-glu and
LDH were determined by conventional methods and expressed as
percent of the total obtained from 1 x iO sonicated PMN. The
aggregating activity was identified in the lipid material extracted with
methanol, purified, and characterized as being identical to 1-
0-octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine (synthetic PAF),
and expressed as nanograms per milliliter. Only cationic, but not
anionic or neutral PMMA membranes, induced a marked release of Lys
(range, 20 to 25%), /3-glu (40 to 43%), and PAF (20 to 25 ng/ml) without
an increase of LDH (2%), as lysis indicator. The amounts of lysosomal
constituents and PAF released after the challenge with cationic PMMA
were quantitatively similar to those obtained with cuprophan mem-
branes (Lys, 24 to 27%; /3-glu, 49 to 53%; PAF, 25 to 30 nglml). These
studies suggest that positive charges on a surface are potent triggers of
PMN activation. Consequently, modification of the electrical net charge
can per se turn PMMA, commonly recognized as inert, into a material
with marked PMN activating effects comparable to those of cuprophan,
a highly reactive biopolimer. In biocompatibility studies, the direct
membrane-PMN interaction may serve as a useful tool for the analysis
of new derivatives from so-called inert polymers such as PMMA.
A membrane defect as a possible pathogenetic factor in idiopathic
calcium nephrolithiasis. B. Baggio, G. Gambaro, F. Marchini, E.
Cicerello, and A. Borsatti. Institute of Internal Medicine, University of
Padua, Padua, Italy. Red blood cell (RBC) steady-state oxalate self-
exchange was measured in 80 renal CaOx stone formers, of whom 70
had a "primary" disease. Compared to control subjects, RBC oxalate
self-exchange was significantly higher in idiopathic stone formers (0.91
0.65 SD X lO2min' vs. 0.31 0,12 x 10-2; t = 4.57; P < 0.001),
while it was in the normal range in patients with "secondary"
nephrolithiasis. An oxalate tolerance test carried out on four pairs of
siblings of whom one was a carrier of the anomaly, demonstrated a
significantly higher percentage of oxalate excretion 2 and 4 hr after the
test in the carrier. From a study of five families, the anomaly seems to
be an autosomal, monogenic, dominant trait with complete penetrance,
variable expressivity, and sex limitation of stone formation. The effect
on oxalate self-exchange of two diuretics, hydrochlorothiazide and
amiloride, was also evaluated. Both drugs are capable of normalizing
abnormal RBC oxalate self-exchange. The study suggests that an
inheritable cellular defect in oxalate transport may be one of the factors
involved in "primary" calcium oxalate stone disease and may be
corrected by the use of diuretics.
Alcohol-associated nephropathy. Prevalence and physiopathological
significance of a complex tubular dysfunction. S. De Marchi, E. Cecchin,
andR. Nardini. Divisione di Medicina, Laboratorio Chimico di Igiene,
USL No? "Udinese," Stabilimento Ospedaliero di Codroipo, Italy.
Electrolyte abnormalities are frequent in chronic alcoholic patients.
Hypokalemia, hypophosphatemia, hypomagnesemia, and hypocalce-
mja are some of the components of the characteristic pattern of
deranged serum composition commonly seen in these patients during
their first days of hospitalization. Even though these electrolyte abnor-
malities are described among the metabolic consequences of alcohol-
ism, their pathogenesis might involve, at least in part, the kidney. The
discovery of an unexplained alkaline urine pH in a significant percent-
age of chronic alcoholic patients prompted us to evaluate some aspects
of their tubular function (1) to define the prevalence and the spectrum of
the tubular defect and (2) to investigate its physiopathological signifi-
cance. We studied 70 patients with a history of alcohol abuse for 10
years or more. Only patients without clinical and histopathological
evidence of chronic liver disease were included in the study. At
admission 26 patients (group 1) showed a urine pH greater than 6.4 and
a daily bicarbonate excretion ranging from 6.4 to 80 mmoles. None of
these patients was in alkalosis. Forty-four patients (group 2) had a urine
pH less than 6.4 and a normal daily bicarbonate excretion. In group 1
patients the fractional urinary excretions of 132-microglobulin, sodium,
potassium, chloride, calcium, phosphorus, and uric acid were higher
than those of group 2, whereas the serum concentrations of these
substances were lower. In the overall group of alcoholic patients there
were close inverse relationships between the fractional urinary excre-
tion of the investigated substances and their serum concentrations. The
assessment of the tubular reabsorption capacity for glucose showed in
group 1 a decrease of the minimal threshold and the maximal reabsorp-
tive capacity. In these patients we found a decrease of urinary ammo-
nium and titrable acid excretion while a brief acidification test with
CaCI2 demonstrated an impaired acidification capacity. All these indi-
ces of tubular function improved with abstinence. In conclusion, (1) in
approximately one third of alcoholic patients without chronic liver
disease, ethanol abuse causes a complex tubular dysfunction. (2) This
"alcohol-associated nephropathy" seems to have a physiopathological
significance in the derangement of serum electrolyte composition of
these patients. (3) In this stage of the alcoholic disease the tubular
dysfunction is reversible and in most cases it recovers with abstinence.
Effects of dietary phosphate (P) intake on serum vitamin D metabolites
in patients with early renal failure (ERF).N. Tessitore, S. Adami, A.
Venturi, L. Gammaro, D. Tartarotti, C. Rugiu, G. Barini, R.
Panebianco, V. Bedogna, V. Ortalda, A. Fabris, L. Oldrizzi, C.
Loschiavo, G. Panzetta, A. Lupo, E. Valvo, and G. Maschio. Istituto di
Nefrologia e Semeiotica Medico, Universitd di Verona, Verona, Italy.
Serum vitamin D metabolites levels have been reported either normal or
low in patients with ERF. Since it has been shown that dietary P intake
is a major determinant of serum i.25(OH)2D also in children with ERF,
we evaluated in 41 adults with ERF (GFR, 30 to 70 mI/mm) the vitamin
Group I
Before After
GFR, mi/mm
s-Ca, mg/dl
s-P, mg/dl
s-PTH, mU/mi
s-1.25(OH)2D, pg/mi
s-24.25 index
u-P, mg/24 hr
46 4
9.3 0.1
3.0 0,2
3.1 0.4
8.8 2.0
4.6 0.8
520 34
47 5
9.8 0.1*
2.8 0.2
2.6 0.2
27.3 2.8*
7.3 0.6*
409 15*
Group 2
Before After
GFR, mi/mm
s-Ca, mg/dl
s-P. mg/di
s-PTH, mU/mi
s-i,25(OH)2D, pg/mi
s-24.25 index
u-P. mg/24 hr
44 4
9.0 0.2
3.5 0.3
2.8 0.5
15.0 6.0
7.4 1.8
494 16
12 2*
9.1 0.1
3.7 0.3
5.2 Ø•3*
11.9 3.1
2.5 1.0*
319 20*
* significant
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D metabolite levels on unrestricted dietary regimen and after 29 2
months on a P-restricted, calcium-supplemented diet (P 700 mg; Ca
1300 to 1800 mg). Under basal conditions, 24.25 index (serum
24.25(OH)2D/25(OH)D x 100) was comparable to control subjects (5.6
0.6 vs. 7.4 0.8, P = NS). Mean serum 1.25(OH)2D levels were
significantly reduced (20.3 2.3 vs. 29.1 2,3 pg/mI, P < 0.05) and
were a function of GFR and phosphaturia, taken as an index of dietary
P intake. Multiple linear regression analysis showed: log 1 .25(OH)2D =
—2.09 + 1.80 log GFR — 0.004 phosphaturia (r 0.792, P < 0.001) with
/3-weight values of 0.64 and —0,49 for log GFR and phosphaturia,
respectively. During P restriction, GFR did not change in 11 out of 17
patients (group 1), while significantly decreased in 6 of them (group 2).
Our study shows that in ERF (GFR, 30 to 70 mI/mm): (1) Serum 24.25
index is normal and serum 1.25(OH)2D may be either normal or low
being a function of GFR and dietary P intake; (2) renal responsiveness
to dietary P restriction by increasing vitamin D metabolites levels is
intact. Our data also suggest that, when GFR is below 20 mI/mm, the
persistently low levels of vitamin D metabolites reflect a marked and
irreversible reduction of their renal synthesis.
Aluminum and erythropoiesis: In vitro effects. S. Lamperi, A. Icardi,
and S. Carozzi. Division of Nephrology and Dialysis St. Martin
Hospital, Genoa, Italy. Aluminum (Al) and other metal ions (Cu, Zn)
were added in gradual dosages to in vitro cultures of Burst Forming
Unit-erythroid (BFU-e) drawn from peripheral blood with progressively
reduced doses of Erythropoietin (Ep) to evaluate the effect of the
above-mentioned materials on the BFU-e growth and Ep sensitivity.
Besides the effect of the same metal ions on the endoerythrocytic delta
aminolevulinic acid dehydrase (D-ALA-D) activity, T-cell growth fac-
tor (TCGF) production from peripheral mononuclear cells and the
lymphocyte blast-cell transformation were evaluated. The results
showed a decrease of BFU-e growth in the presence of Al and Cu in the
cultures, respectively about 33 and 28%, and a reduced Ep sensitivity.
Zn showed no effect. A decline of D-ALA-D activity, TCGF produc-
tion, and lymphocyte blast transformation in the presence of Al and Cu
were also observed. The above-mentioned data were obtained with Al
and Cu concentrations, respectively >1.2 m and >0.6 m, equivalent
to in vivo toxic levels. In conclusion, our results show that Al is capable
of determining in vitro cellular abnormalities which could contribute in
vivo to some hematological and immunological disorders of uremia.
Possible role of the blood brain barrier in the pathogenesis of alumi-
num-induced encephalopathy in patients undergoing regular dialytic
treatment. D. Brancaccio, 0. Bugiani, L. Pacini, J. Bisceglia, M.
Gallieni, G. Brighenti, P. Padovese, M. Surian, C. Costantini, R.
Giordano, and A. Berlin. Servizio di Nefrologia, Ospedale S. Paolo,
istituto Neurologico C. Besta, and Servizio di Emodialisi, Ospedale di
Lodi, Milano, and Istituto Superiore di Sanità, Roma, Italy; Commis-
sion of the European Communities, Luxembourg, Belgium. Aluminum
(Al) may be considered responsible for a complex dialytic syndrome,
whose main features are represented by encephalopathy and
osteomalacic osteodystrophy. However, the reasons why some patients
develop encephalopathy, while other present bone involvement are not
yet elucidated, assuming that all patients follow the same dialytic
treatment in terms of Al-gels and dialysate purity. A neurological
protocol has been arranged, with the aim of investigating the possible
pathogenetic factors responsible for dialysis encephalopathy; sixteen
informed patients presenting clinical or serological evidence of Al
intoxication were included in the study. They underwent spinal fluid
and plasma Al measurements, evaluation of blood brain barrier perme-
ability to albumin and IgG, motor and sensorial nerve conductivity,
brain CT scan, and a clinical neurological examination. Two distinct
groups of patients (11 vs. 5) could be individualized on the basis of the
results of our investigation: The first one includes patients without
neurological abnormalities having low Al levels in their spinal fluid,
even in presence of high plasma levels; the other group includes
patients having clinical and/or EEG evidence of neurological involve-
ment, furthermore presenting higher spinal fluid Al concentrations (> 5
pg/liter). Our data support the hypothesis that a blood brain barrier
derangement with increased permeabilty to aluminum may play a role in
inducing dialysis eneephalopathy.
Hemofiltration without substitution fluid (HWSF): Physiopathological
considerations and clinical notes after 1500 sessions. G. Civati, C.
Guastoni, U. Teatini, A. Perego, M. L. Perrino, C. Brunati, and L.
Minetti. Renal Unit, Niguarda Ca'Granda Hospital, Milano, Italy.
HWSF is a new proposal for a physiologic approach to renal replace-
ment therapy; high flux pure convected ultrafiltrate (190 10 mI/mm) is
regenerated through a large area highly permeable dialyzer and then
reinfused, only deprived of the desired weight loss. On the average,
clearances of 190 mllmin for urea and 75 mi/mm for inulin could be
obtained during the whole run. As the measured sodium concentration
in the pure convected ultrafiltrate is lower than in the true plasmatic
water, the diffusion across the dialyzer usually happens in isonatric or
lightly hypernatric mode when a sodium dialysate between 135 and 140
mEg/liter is used. So, sodium balance in such a closed system is easily
predictable from the weight loss volume. Despite a 40 mEq/liter acetate
dialysate, HWSF receives consistent bicarbonate savings. In fact,
bicarbonate-poor dialyzed ultrafiltrate mixes with unultrafiltered
plasma amounts at systemic bicarbonate concentration so that bicar-
bonate concentration is still remarkable at the reinfusion side. On the
other hand, acetatemic levels are moderate, because of mixing between
the slowly increasing arterial concentration and the higher one of the
dialyzed ultrafiltrate. The size of these phenomena depends on the
proportion between the convected-dialyzed volumes and the convec-
tion escaping ones. Fifteen hundred WHSF sessions were performed in
six free-diet patients coming from other depurative techniques including
high efficiency hemofiltration (HEUF = 2 LUF/kg/week). Clinical
benefits of HEHF, including lack of polineuropathy and Ca-P equilib-
rium, were all maintained without side effects. HWSF, whose peculiar
features could explain the vascular stability and dialytic comfort, could
be a valid alternative among the newest ways to replace renal function.
Costs, which are already lower than HEHF because of lack of substi-
tution fluid, could be lowered by future improvements in hemofilters
and regenerators.
Glomerular prostaglandins (PGs) and thromboxane (TX) synthesis In
normotensive (MNS) and hypertensive (MHS) rats of the Milan strain
before and after development of hypertension. F. Pugliese, P. Mené, and
G. A. Cinotti. Departments of Medicine, Division of Nephrology,
University of Rome "La Sapienza," Italy. Young pre-hypertensive rats
of the Milan strain (MHS) have a faster glomerular filtration rate (GFR)
and an increased renal plasma flow (RPF) than age-matched
normotensive control rats (MNS). Adult hypertensive MHS show a
lower RPF and a whole-kidney GFR maintained within the normal
range by an increased single-nephron GFR. Since the renal glomerulus
is capable of synthesizing vasoactive PGs and TX which have profound
effects on glomerular hemodynamics, we have compared the synthesis
of PGs and TX in isolated and incubated glomeruli from MNS and MHS
in both the pre-hypertensive and hypertensive phase. We used radio-
immunoassay to measure POE2, 6-keto-PGF1 (a metabolite of
prostacyclin) and TXB2 (a metabolite of TXA2). The relative abundance
of the compounds was similar in MNS and MHS, that is, PGE2 >
TXB2-6-keto-PGF1. However, glomeruli from young MHS showed a
significant higher synthesis of PGE2 as compared to matched MNS (8.8
3 vs. 3.8 0.8 pg/ag of protein; 45 mm of incubation, mean SD, P
< 0.001). There were no significant differences in 6-keto-PGF1c, and
TXB2 production in both groups. Conversely, glomerular PGE2, 6-keto-
PGF1,, and TXB2 in adult MHS were significantly lower than that of
matchedMNS (4.76 2, 1.09 0.3, and 1.3 0.39 vs. 8.5 4, 1.75
0.5, and 2.6 0.9, respectively, all P < 0.01). We conclude that the
changes in renal hemodynamics observed in pre-hypertensive and
hypertensive MHS are associated with a change in glomerular PGs and
TX synthesis.
Contribution of angiotensin to the vasomotor response to reflex sym-
pathetic activation in humans. A. Morganti, G. Grassi, C. Sala, A.
Capozi, L. Turolo, E. Sabadini, G. Bolla, G. Mancia, and A. Zanchetti.
Istituto di Clinica Medica IV, Universitd di Mi/mw and Centro di
Fisiologia Clinica e ipertensione, Ospedale Maggiore, Milano, Italy. In
vitro and animal studies have shown that angiotensin II (All) can
potentiate sympathetic nervous activity; however, it is still unclear
whether this interaction has physiological relevance in humans. Thus,
to examine whether All participates in the vascular control exerted by
the sympathetic nervous system (SNS) we measured, in 12 patients
with essential hypertension, mean arterial pressure (MAP, mm Hg),
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forearm blood flow (FBF, mi/mm, plethysmography), plasma noradren-
aline (NA, pg/mi) and plasma renin activity (PRA, ng/mllhr) before and
after 30 mm of deactivation of cardiopulmonary receptors induced by a
moderate reduction in central venous pressure (—2mm Hg) provided by
lower body suction (LBS). The effects of LBS were studied in control
conditions (C), 1 hr after converting enzyme inhibition (acute CE!),
induced by administration of 25 mg Captopril and after 5 to 7 days of
treatment with Captopril 25 mg tid (chronic CE!, N = 8). In C, LBS
caused an insignificant reduction in MAP (—1.8 1.2) associated with
significant (P < 0.05) decrements in FBF (—1.7 0.2) and increments
in NA (+84 32) and in PRA (+0.6 0.2). Acute CE! lowered baseline
MAPfrom 120 7to Ill 6andincreasedPRAfrom 1.8 0.7to8.0
5.0 (P < 0.01 for both) whereas baseline FBF and NA were
unchanged respect to C values (4.1 0.3 vs. 3.9 0.3 and 361 36 vs.
292 25). During LBS the change in MAP was slightly more pro-
nounced (—4.4 3.6) while the responses of FBF, NA, and PRA were,
respectively, smaller (—0.8 0.1, P < 0.05), similar (+ 118 58) and
greater (+4.0 2.0, P < 0.05) than those observed in C. Chronic CE!
lowered baseline MAP to 98 4 and increased PRA to 5.6 1.8 (P <
0.01 for both) while leaving baseline FBF and NA unchanged. The
LBS-induced changes were superimposed to those seen during acute
CE!. Thus, during acute and chronic blockade of All formation, the
vascular, though not the renin, response to LBS was reduced. Since the
NA response was unimpaired this suggests that A!! contributes to the
vasoconstrictive ability of SNS either through a direct vascular action
or through an enhancement of the vascular responsiveness to NA.
Immunological features in patients with insulin-requiring diabetes and
early nephropathy. A. Nanni Costa, G. Orsoni, S. Stefoni, L. C.
Borgnino, S. Jannelli, T. D'Atena, E. Lazzari, A. Ciavarella, P.
Vannini, and V. Bonomini. Nephrology and Dialysis and Metabolic
Diseases Departments, S. Orsola University Hospital, Bologna, Italy.
Full-blown diabetic nephropathy develops in only about 4 out of 10
patients with type I or insulin-dependent diabetes mellitus (IDDM),
depending in part on the adequacy of long-term metabolic control and
probably on still unknown predisposing factors. Since there is a growing
evidence that the immune response has a role in the onset of the disease
as well as in some long-term microangiopathic complications, we have
investigated IDDM patients both with and without proteinuria to
eventually detect immunological abnormalities related to the renal
involvement. Twelve patients with proteinuria of recent onset (higher
than 500 mg/liter) and normal creatinine clearance, and 16 patients
without proteinuria (with similar age, duration, and metabolic control of
!DDM), have been considered. Immunological work-up included: (1)
phenotyping of lymphocyte subsets by means of monoclonal antibodies
previously described as specific for total T cells (OKT3), T
helper/inducer (OKT4), T suppressor/cytotoxic (OKT8), T precursor/
activated (OKT1O), T helper alloactivated (5/9), and natural killer (Leu
7) cells; (2) total B cell count (surface immunoglobuline-SIg-positive
cells); (3) in vitro evaluation of lymphocyte proliferative response to
Phytoemagglutinin (PHA), Concanavalin A (Con A), and Pokeweed
(PWM); (4) assessment of suppressor cell activity (SCA) by the Con A
enhancement test. The patients with early nephropathy exhibited a
higher percentage of Leu 7 positive natural killer cells (mean SEM: 15
3vs. 5 l)andaslightincreaseoftheOKT4/OKT8ratio(l.6 0.2
vs. 1.2 0.1). The total B and T cell counts, the relative percentages of
T4, T8, Tb, and 5/9 positive cells as well as the dose/response curves
to PHA, Con A, and PWM and the SCA were not statistically different
between the two groups. Even if the results do not allow any definitive
pathogenetic conclusion, they do actually indicate the presence of some
immunological differences between nephropathic and non-nephropathic
IDDM patients. In searching for early markers of diabetic nephropathy,
the increase of natural killer cells deserves further investigation.
Effect of piroxicam (P), an inhibitor of cyclooxygenase activity, on the
glomerular hyperfiltration of type I newly diagnosed diabetic patients. G.
Stirati, S. Gambardella, P. Pietravalle, A. Napoli, A. Messina, I.
Cardamone, and F. Pugliese. Department of Medicine, Divisions of
Nephrology and Endocrinology, University of Rome "La Sapienza",
Italy. Increased glomerular filtration rate (GFR) has been observed
frequently in the early phase of diabetes meffitus and may be involved
in the subsequent development of glomerular damage. The renal
glomerulus converts arachidonic acid to vasoactive prostaglandins
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(PGs) and thromboxane (TX), which have profound effects on glomer-
ular hemodynamics. Since recent evidence of an increased PGs pro-
duction has been shown in isolated gbomeruli from diabetic rats, we
studied the functional importance of renal cyclooxigenase products in
renal hemodynamics of six type I diabetic patients (pts) at onset (5
male, 1 female, aged 12 to 23) by treatment with P (20 mg/day); these pts
did not receive insulin throughout the study. GFR, evaluated as
creatinine (Cr) and 99Tc-DTPA clearances (C), renal plasma flow
(RPF), evaluated as 131!-Hyppuran C, daily urinary excretion of
6-Keto-PGF1, (a metabolite of prostacyclin), and TXB2 (a metabolite of
TXA2) were measured before, during, and after P treatment. After 1
week of P treatment Car, CTDTPA, and C1311H were reduced by 11,
12.5 and 6%, respectively (138.6 18 vs. 157 33; 157.6 14.8 vs. 180
33; 538.7 83 vs. 573.5 103 mllmin, mean SD, NS). Diabetic pts
showed a basal urinary excretion of 6-Keto-PGF1 significantly higher
than that of 12 aged- and sex-matched healthy subjects (4.93 2.31 vs.
13.19 5.18 ng/hr, P < 0.023). No differences in urinary excretion of
TXB2 were observed. After P, urinary excretion of 6-Keto-PGF1,
albeit reduced by 66%, was comparable to the baseline excretion of
normal control subjects (4.9 0.9 vs. 4.93 2.31); urinary TXB2 was
reduced by 63%. We conclude that P does not significantly modify
glomerular hemodynamics in type ! newly diagnosed diabetic pts.
However, urinary excretion of 6-Keto-PGF1 is increased in these pts,
suggesting that an increased renal synthesis of prostacycin might be
one of the many causative factors of hyperfiltration in the early phase of
diabetes mellitus.
A Simple and fast method to get a suspension enriched in proximal
tubules in the rat. Effect on 0 consumption of ouabain, amphotericin B,
nystatin, and CCCP. G. Capasso, S. Gullans, N. G. De Santo, C.
Giordano. 1st Faculty of Medicine, Institute of Internal Medicine and
Nephrology Naples, Italy, and Yale University Medical School, New
Haven, Connecticut, USA. !n recent years the use of cortex slices for
the study of renal metabolism has been strongly criticized, stimulating
the research of new tissue preparations. In the present study we
describe a simple and fast method to isolate proximal tubule suspension
from rats. The left kidney of 250 to 300 g rats has been perfused at 37°C
for 15 mm, via aorta, with a modified Ringer solution containing 0.1%
collagenase (Sigma, 180 U/mg). The perfusion rate was 3 cc/mm. The
tubules were obtained from thin slices of renal cortex that were left for
15 mm on a magnetic stirrer. They were separated from the glomeruli
and from other dead cells by two times 10 mm sedimentations at 1 g.
The examination at light and electron microscopy revealed the presence
of 80 to 95% proximal tubules with open lumens and intact brushborder
membranes. The 02 consumption rate (Q02) expressed as nmoles 02
mg proteins min' and measured with a Clarck electrode utilizing a
300-sl micro-chamber, was 44.2 2.1 (mean SEM) in control
conditions. However, it was significantly reduced to 20.7 3.2 (P <
0.001) in the presence of 5 ma ouabain, a well-known inhibitor of
Na-K-ATPase. On the other hand, the use of sodium ionophore
substances enhanced Q02 consumption: It increased to 55.3 3.2 in the
presence of 20 sg/ml of Amphotericin B and to 65.5 2.1 with 100
jsg/ml Nystatin. Finally QO2 was 72.3 4.2 by adding the uncoupler
CCCP to the tubule suspension. These data demonstrate that it is
possible to isolate, within 60 mm, intact proximal tubules that are
sensitive to the action of substances that inhibit and stimulate renal
metabolism.
Relationship between ATP content, Na-K-ATPase activity, and luminal
active transport processes in isolated renal cortical cells. N. Tessitore, L.
M. Sakhrani, and S. G. Massry. Istituto di Nefrologia Medica,
Universitd di Verona, Verona, Italy, and Division of Nephrology, Los
Angeles County/University of Southern California, Los Angeles, Cali-
fornia, USA. Studies with renal cortical membranes show that Na-K-
ATPase saturates at 1 to 2 mr.i ATP. Since in vivo ATP is greater than
2 mti, it is accepted that renal tubular transport processes are not
limited by ATP. We investigated the quantitative relationship between
cellular ATP concentration, Na-K-ATPase activity (as measured by
ouabain sensitive Rubidium influx) and Na-dependent phosphate (P)
and alphamethylglucoside (AMG) uptake in the intact renal cell. Iso-
lated rabbit renal cortical cells were obtained by hypertonic citrate
perfusion; their viability was ascertained by normal rates of glucose
production, its stimulation by agonists and cellular ATP content of 4.5
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m. Cellular ATP was increased by 10 ms adenosine and was reduced
in a stepwise manner by rotenone (0.1 to 10 tM). During these
manuvers ouaban-sensitive 86Rb influx was linearly related to cellular
ATP (r = 0.90, P < 0.001) and did not saturate up to 9 mi ATP. In
contrast, Na-K-ATPase activity in membranes prepared from these
cells saturated at 2 mrvi ATP. With partial decrease in cellular ATP
(50%), the early phases (I mm) of the Na-dependent uptake of P and
AMG were reduced by 20%; at ATP zero, both P and AMO uptakes
were similarly reduced by 40%, We conclude: (1) the ATP requirement
for Na-K-ATPase is higher in the intact renal cell than in membrane
preparations and does not saturate even at ATP of 9 m in the former;
(2) cellular ATP content is an essential limiting factor for active
transport processes in the intact renal cell; (3) the luminal influx of P
and AMG depends on energy to the same degree.
Deposits of cyclosporine in the renal allograft. P. Scaini, R. Tardanico,
M. Favret, F. Scolari, S. Savoldi, E. Prati, S. Sandrini, G. Brunori, L.
Cristinelli, andR. Majorca. Department of Nephrologyand 1st Depart-
ment of Pathology, Spedali Civili, Brescia, Italy. Cyclosporine (Cs)
deposits have been described in renal parenchymal cells obtained by
fine-needle aspiration biopsy (FNAB), directly correlated with cyto-
logic morphological changes and clinical drug nephrotoxicity. To verify
the clinical usefulness of this finding, we have evaluated 94 FNABs
obtained from 32 renal transplant recipients, treated with Cs and
Methyiprednisolone. An indirect imniunoperoxidase technique was
used to detect cellular Cs deposits. Deposits of Cs in the tubular and/or
endothelial cells were found in 44 FNABs from 22 patients (group A),
while in 50 FNABs there was no evidence of Cs deposits (group B). At
the time when FNABs was performed, Cs blood through levels (BTLs)
were 411 35 ng/ml (means SE) in group A and 347 47 in group B
(P = NS); Cs mean dose was 10.4 4 mg/kg/day in A (means SD)
while it was 11.2 4 in B (P NS). Twenty-one out of the 94 FNABs
were performed at month 6 as controls in patients with stable renal
function. Nine of 21 patients had Cs deposits in their renal parenchymal
cells; Cs dose-administered (11 3 mg/kg/day) and Cs BTLs (398 66
ng/ml) were not statistically different in these patients from those of the
12 patients without Cs deposits (Cs dose 9.1 2.9 mg/kg/day; Cs BTLs
380 42 ng/ml). In the first 3 months Cs BTLs 300 ng/ml were
associated with a higher incidence of Cs deposits (21; 65.6%) compared
to Cs BTLs < 300 ng/ml (11; 34.4%) (P < 0.05; X2 test). Clinical
nephrotoxicity was observed in 5 patients of group A, associated with
cytologic signs of drug toxicity and BTLs >500 nglml. Our results show
that Cs deposits, taken alone, cannot be considered as a clinical sign of
nephrotoxicity.
Comparison of renal biopsy (RB) and fine-needle aspiration biopsy
(FNAB) in renal transplantation (TX). F. Egidi, G. Banfi, A. De Vecchi,
M. Moriggi, and C. Ponticelli. Divisione di Nefrologia e Dialisi -via
Commenda 15 Ospedale Maggiore, Milano, Italy. RB and FNAB were
simultaneously performed in 86 renal transplant patients (pts), 29 in
conventional immunosuppression and 57 on Cyclosporine (Cs) and
low-dose steroids. RB: 4 histological classes of rejection (rej) were
defined (I, mild; 2, moderate; 3, severe, 4, irreversible) and a
semiquantitative score from 0 to + + + was assigned to infiltration
(interstitial, pertubular, glomerular), vascular intimal proliferation, tu-
bular damage, tubular, and vascular Cs toxicity. FNAB: a conventional
score (CI) was attributed to each type of infiltrating cell; CI above 3.5
was considered significant for inflammation. A semiquantitative score
from 0 to + + + was used to evaluate the degree of tubuloendotehlial
cells damage at FNAB. In the early post-TX period (49 cases) the
cytological and histological diagnoses agreed in 44/49 cases (2 normal
pattern, 2 acute tubular necrosis, 9 rejections, 10 rejections + acute
tubular necrosis, 13 rejections + Cs toxicity, 8 total necrosis). Con-
versely, in 2 cases the presence of mild inflammation at FNAB was
conterparted by a histological diagnosis of thrombotic microangiopa-
thy. In two samples with high CI at FNAB, RB did not show any sign
of rejection. In the late post-TX, (56 cases) the FNAB and RB
diagnoses agreed in 34/56 cases (6 normal pattern, 15 rejections, 9
rejections + Cs toxicity, 3 Cs toxicity, and 1 acute tubular necrosis). In
11 cases with normal patterns at FNAB, RB showed interstitial fibrosis
+ TX glomerulopathy (4 pts), mild rejection (2 pts), and stripe fibrosis
(1 pt). In 3 cases with typical Cs toxicity at FNAB, RB showed only a
nonspecific tubular damage and mild fibrosis. In 8 cases showing at RB
stripe fibrosis and Cs arteriolopathy, tubuloendothelial cells detected at
FNAB appeared particularly damaged and picnotic. A relationship
between the CI and histological classes of rejection was found; further-
more, rejection which reversed after therapy had a mean CI = 6.3
1.8, while irreversible rejection had a CI = 10.1 1.7 (P < 0.001). The
histologic score was 1.6 0.7 in reversible rejection and 2.9 0.8 in
irreversible rejection (P < 0.001). Macrophages were more frequently
present in severe and irreversible rejection (1.8 1.3) than in mild and
moderate rejection (0.85 1.2) (P < 0.05). A good correlation was
observed between the semiquantitative scores of tubular lesions as-
sessed by FNAB and RB. In conclusion, FNAB can provide informa-
tion comparable to that of RB about the tubular lesions and the degree
of inflammatory activity of the TX kidney, but RB can better assess the
prognosis of the TX through the analysis of vascular and glomerular
lesions either caused by rejection or Cs toxicity.
Use of HLA-A, B compatible blood tranfusions in the candidate for
cadaver kidney transplant. G. Triolo, G. P. Segoloni, A. Amoroso, I.
Borelli, E. S. Curtoni, and A. Vercellone, Chair of Nephrology,
Genetical Inst itute, University of Turin, Turin, Italy. Although blood
transfusions are now compulsory in all protocols designed in prepara-
tions for transplantation, the intrinsic risk of immunization to histocom-
patibility antigens constitutes a limit to the number of patients who may
benefit from their positive effect. Among various proposals for reducing
immunization, the use of HLA-A, B compatible blood units has been
suggested. This protocol has been adopted in 231 uremic patients on the
waiting list for transplantation who had received no transfusion before.
Out of 513 units of blood, 33% were totally compatible, 54% had one
mismatch and the remainder (13%) two mismatches. HLA-A B anti-
bodies were searched 15 days after each transfusion and then every 2
months and were detected in 11 of 193 patients examined (5.7%), No
HLA-A, B antibodies were detected after transfusing totally compatible
blood. Fifty-five of these patients (I) received a cadaver transplant.
Age, HLA-A, B and DR mismatch, immunosuppressive treatment,
ratio M/F did not differ from 77 patients previously randomly transfused
(II), who had a transplant in the same period of time, the latter having
longer dialytic age, a higher number of transfusions, and a longer period
between transfusion and transplantation. Graft survival in patients
treated with azathioprine was 82 and 76% at 3 and 12 months, in (I)
versus 79 and 74% in (II). Patients treated with Cyclosponn A showed
95% at 3 and 6 months in (I) versus 88 and 80% in (II). Because of the
possibility of obtaining an extremely low level of immunization and also
a graft survival rate not different from randomly transfused patients,
HLA-A, B compatible blood transfusions appear a sound choice in
candidates for kidney transplantation who have never been transfused
before.
Cyclosporin A in cadaveric renal transplantation. A. Tarantino, A. De
Vecchi, G. Montagnino, E. Rivolta, F. Egidi, A. Vegeto, L.
Berardinelli, and C. Ponticelli. Nephrology and Transplant Surgery
Divisions, Ospedale Maggiore, Milano, Italy. Between February 1983
and February 1985, 142 cadaveric renal transplant patients (pt) were
treated from the day of surgery by Cyclosporin A (Cs) alone (28 pts) or
associated to low-dose steroid (114 pts). Patient survival at both 1 and
2 years was 96%; graft survival was 88% after 1 year and 85% after 2
years. Mean serum creatinine at 1 year was 1.57 0.5 mg/dl. Causes of
death (5 pts) were: cerebral hemorrhage (1), CMV interstitial pneumo-
nia (2), bacterial endocarditis (1), and sepsis from wound infection (1).
Causes of graft failure (14 pts) were: rejection (10), nonviable kidney
(2), septic arteritis (1), and kidney rupture (I). Ninety-two patients
(65%) had no acute rejection episode. Twenty-six pts (18%) were
changed to azathioprine (17) or triple therapy (9) due to: (a) Cs
arteriolopathy (11), (b) prolonged post-transplant renal failure (7), (c)
renal function deterioration in the absence of signs of rejection (6), (d)
nephrotic syndrome (1), (e) hemolytic anemia (1). In patients from
groups a, b, and c mean plasma creatinine levels before and after the
change of therapy were: (a) from 3.8 to 1.9 mg/dl; (b) from 9.2 to 1.01
mg/dl; (c) from 2.8 to 2.0 mg/dl. Three out of 26 had a rejection episode
immediately after conversion, and in two of them with a steroid
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resistent rejection Cs had to be restored. Among the severe complica-
tions, we observed 11 cases of severe and refractory hypertension, 23
severe bacenal or viral infections, 17 cases of diabetes, 4 Achilles
tendon inflammation episodes, 3 gastrointestinal hemorrhages, 1
mycoardial infarction, 1 Burger's disease, 1 aseptic bone necrosis, 1
hemolytic anemia, and 1 episode of seizures. In conclusion, in our
series, two thirds of the patients with renal graft from cadaveric donors
did not present any rejection episode. Rejections were reverted by
therapy in 80% of cases. Cs has therefore allowed considerably reduc-
tion of the incidence and severity of acute rejections as compared to
conventional therapy. On the other hand, it can be associated to severe
effects that require a careful and intensive monitoring of both renal
(renal biopsy, fine-needle aspiration) and extrarenal situation.
Effects of cyclosporine on lymphocyte activation cascade. B. Brando,
G. Civati, L. S. Belli, G. Busnach, C. Brunati, P. Torricelli, and L.
Minetti. Renal Unit, Niguarda, Ca'Granda Hospital, Milano, Italy. In
a previous study we demonstrated a lower expression of peripheral
lymphocyte activation markers OKT1O and transferrin receptor (TR)
and a lower percentage of cells in the S and G2M phases of cell cycle in
renal transplant recipients treated with Cyclosporine (CSA). This
feature was evident both during quiescence states and during immune
events like rejection and infection. We developed an in vitro model to
evaluate the effects of CSA on lymphocyte activation cascade, as
measured by tritiated thymidine (3H-TdR) incorporation, cell cycle
analysis, and surface activation marker expression by flow cytometry.
In vitro stimulation was performed by PHA or by a mixture of the
calcium ionophore lonomycin plus the phorbol ester TPA for 24, 48, 72,
96 hr, respectively. In vitro CSA inhibits the 72 hr 3H—TdR incorpo-
ration by 86% at 50 ng/ml and by 100% at 200 ng/ml. CSA inhibited
normal cells from entering the S+G2M phases of cell cycle in a dose—
dependent way. Cells from transplant patients receiving CSA were less
able to enter S+G2M phases upon stimulation. The level of spontane-
ous S+G2M cells correlated inversely with blood CSA (y = 0.OOl8x
+5.17, r =
—0.24, P = 0.00346). In vitro CSA permits the expression of
early surface activation markers TAC and MID-6 even at 200 ng/ml,
while TR, OKT1O and la—like antigens that appear later are inhibited
by 100% at 50 ng/ml. It is concluded that CSA does not block the
earliest steps of cell activation and does not prevent antigenic or
mitogenic priming of the immunocompetent cells. The surface activa-
tion markers that are associated with DNA synthesis are blocked in
vitro. These data may help explain the poor expression of lymphocyte
activation markers that is demonstrable in vivo.
Plasmapheresis (PP) in the treatment of acute renal graft rejection. G.
M. Frascâ, A. Vangelista, A. Di Felice, G. Liviano D'Arcangelo, M. G.
Facchini, P. Zucchelli, G. Sermasi, and V. Bonomini. Institute of
Nephrology, Immunohernatology Department, St. Orsola University
Hospital, Bologna, Italy. PP has been used in renal transplantation
following various clinical indications. However, the results reported
until now are still conflicting so that it is not well-established whether
PP is effective in transplanted patients. We used this technique in
patients with acute vascular rejection (AVR) unresponsive to high-dose
steroids, and circulating anti-HLA antibodies against donor's antigens.
The present study reports the clinical course and outcome observed in
44 transplanted patients with AVR, 23 of whom underwent PP treat-
ment, while 21 (control group) received pharmacological therapy alone.
PP treatment consisted of three to seven sessions performed daily or on
alternate days. In both groups cyclophosphamide was added when
specific anti-HLA antibodies were detected. The PP group showed a
statistically significant improvement in graft function, which was not
observed in the control subjects. Thirty percent of the PP patients lost
their graft, compared with 82% in the control group. The actuarial graft
survival at 1 year from rejection was significantly higher in the PP
group. Our results suggest tha PP combined with adequate immunosup-
pressive therapy is effective in controlling AVR unresponsive to high-
dose steroids.
